Markets › LSE › SCLP.L

Scancell Holdings plc

LSE:SCLP.LHealthcareFTSE:AIM1FTSE:AXX

£0.0940+1.08%Delayed 15 minIn session · ≈ AED 0.4596 · Market cap $151.71M · Next earnings Fri 23 Oct

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	FY2025	Current · undated	YoY
Gross margin	—	—	90.0%	—	76.3%	—	—	—
Operating margin	—	—	−226.1%	—	−318.4%	—	−318.4%	—
Net margin	—	—	−226.4%	—	−260.5%	—	−260.5%	—
EBITDA margin	—	—	−231.2%	—	−269.7%	—	—	—
Return on equity	−79.4%	−11.4%	191.5%	167.2%	320.0%	92.2%	320.0%	+227.8 pts
Return on assets	−175.5%	−4.2%	−39.4%	−24.9%	−53.1%	−172.8%	−53.1%	+119.6 pts
Return on capital employed	−149.5%	−30.5%	−44.2%	−106.3%	404.1%	90.0%	—	—
Debt / equity	0.8×	1.0×	−3.4×	−5.7×	−4.2×	−0.9×	−4.2×	−382.0%
Debt / assets	174.5%	38.6%	69.8%	84.3%	70.5%	164.9%	—	—
Interest coverage	−5.9×	−4.9×	−9.8×	−16.8×	−8.7×	−8.9×	—	—
Current ratio	19.5×	14.1×	7.5×	3.4×	0.8×	0.3×	0.8×	+172.3%
Quick ratio	19.5×	14.1×	7.5×	3.4×	0.8×	0.3×	—	—
Cash ratio	17.9×	17.9×	6.1×	2.3×	0.6×	0.2×	0.6×	+252.0%
Asset turnover	0.0×	0.0×	0.2×	0.0×	0.2×	0.0×	—	—
Inventory turnover	—	−9.4×	—	—	—	—	—	—
Receivables turnover	0.0×	0.0×	1.2×	0.0×	1.3×	0.0×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—